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Abstract
Background: Refined grains and white rice have been associated with elevated risk of type 2 diabetes mellitus
(T2DM). In this study, we sought to quantify the effect of white rice intake on incident T2DM in two prospective
population-based cohort studies from Iran, where white rice is one of the main staple.
Methods: We used follow-up data from 9,182 participants from Golestan Cohort Study (GCS, 2004–2007, conducted
mainly in rural areas) and 2,173 from Tehran Lipid and Glucose Study (TLGS, 2004–2006) who did not have T2DM
and other chronic diseases at baseline. Diet was assessed using validated food frequency questionnaires.
Multivariable logistic regression models were used to estimate adjusted odds ratios (ORs) for incident T2DM.
Results: We documented 902 new cases of T2DM in GCS and 81 in TLGS. Age-standardized cumulative incidence
of T2DM was 9.9% in Golestan and 8.0% in Tehran. Daily white rice intake was significantly higher among residents
of Tehran compared to Golestan (median daily intake: 250 vs. 120 grams; P-value < 0.001). After adjustment for
potential confounders, there was no significant association between daily white rice intake and incident T2DM in
GCS. In TLGS, the adjusted OR (95% confidence interval (CI)) was 2.1 (1.1, 3.9) comparing participants with
daily white rice intake of >250 grams/day to those with <250.
Conclusions: We observed an increased lieklihood of T2DM associated with high white rice intake among residents
of Tehran and no association in Golestan. Our findings, if further supported by other studies, have important public
health implications especially for countries where white rice is a major staple and diabetes is increasing rapidly
incidence is high. Further research is needed to investigate lack of an association between lower levels of white rice
intake and T2DM.
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Background
Prevalence of type 2 diabetes mellitus (T2DM) is in-
creasing globally [1]. Once considered “a disease of afflu-
ence”, T2DM is now a worldwide threat with
substantially more cases in low- and middle-income
countries (LMIC) where resources for prevention, con-
trol and management are limited. The Middle East is
estimated to have the greatest relative increase in the
prevalence of T2DM by 2030 [2]. Prevalence of T2DM
in the region was above 10% in 2008 according to the
global burden of disease estimates [1]. The prevalence of
T2DM among Iranian adults was 8.7% in 2007 based on
the third national Surveillance of Risk Factors of Non-
Communicable Diseases survey [3] and a 35% increase
in diabetes prevalence has been reported between 2005
and 2011 [4]. The prevalence of T2DM for Iran in 2014
was 11.4% (7.2–17.2) according to the latest global bur-
den of disease estimates [5]. Also, the standardized inci-
dence rate of T2DM in adults living in Tehran (above
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20 years) was 10.6 per 1000 person-year corresponding
to an annual incidence rate of about 1% [6].
Nutritional transition with a more calorie-dense diet
and higher consumption of refined carbohydrates (e.g.,
white rice) may play an important role in the rapid in-
crease in T2DM rates [7–9]. White rice is a staple food
in many LMIC facing rapid economic development and
nutritional transition. Higher white rice intake has been
associated with increased risk of T2DM, particularly in
Asian countries [10, 11]. Results of a recent meta-
analysis showed a significant 11% increase in risk of
T2DM for each additional serving of white rice [12]. In
their meta-analysis, Aune et al also reported a 23% in-
crease risk of diabetes with each additional serving of
white rice per day [13]. The milling process converts
brown rice to white rice removes the majority of fibers,
vitamins and minerals of the grain, which have been
shown to have anti-diabetic properties [14, 15]. Add-
itionally, white rice has a higher glycemic index (GI)
compared to brown rice and other whole grains [16].
High GI diets have been consistently associated with ele-
vated risk of T2DM in several prospective cohort studies
[11, 17–19].
Iran is the 13th biggest white rice consumer worldwide
with an average annual per capita consumption of an ap-
proximately 34 Kg [20]. These high levels of intake in
addition to other lifestyle changes such as increased
interest in fast and junk food, excessive eating and inad-
equate physical activity [21, 22] might contribute to the
rising rates of T2DM in Iran. However, there has been
no analysis of the association between white rice intake
and incidence of T2DM in Iran. Therefore, we used data
from the Golestan Cohort Study (GCS), conducted in
the largely rural province of Golestan, and the Tehran
Lipid and Glucose Study (TLGS), conducted in Tehran,
to investigate the association between white rice intake
and T2DM in populations under different stages of eco-
nomic development.
Methods
Selected cohorts and the study population
Details on the design of both studies have been reported
before [23, 24]. GCS was launched in 2004 in Golestan
province, Northeast of Iran and recruited 50,045 adults
aged between 40 and 87 years from Gonbad city and 326
rural villages (20% urban, 80% rural). Five years after re-
cruitment, a random sample of about 12,000 participants
were invited to participate in a re-measurement study.
The same questionnaires were filled and all participants
were asked to give 30 ml of blood for biomarker mea-
surements including fasting plasma glucose (FPG) and
hemoglobin A1c (HbA1c). We used data from the re-
measurement sub-sample in this analysis.
Tehran Lipid and Glucose Study (TLGS) enrolled
15,005 participants who were 3 years of age or older res-
iding in the 13th district of Tehran, between 1999 and
2001. Participants are being followed up every 3 years by
trained interviewers. Here, we used data from adults
20 years and above who participated in the third (2006–
2008) and forth (2009–2011) phases of the study. The
follow-up between the third and forth phases of TLGS
ranged from 1 to 5 years.
We excluded participants with T2DM (self-reported in
GCS and diagnosed with blood measurements or receiv-
ing anti-diabetic medications in TLGS), and other non-
communicable diseases at baseline (Figs. 1 and 2). We
excluded individuals with T2DM at baseline in both
studies to ensure individuals with prevalent diabetes are
not included in the analyses.
Exposure assessment
GCS
Dietary information was collected using a validated food
frequency questionnaire (FFQ) specifically developed for
this population [25]. Information on the typical portion
size, consumption frequency, and the number of serv-
ings consumed each time was collected for each food
item at enrollment. Daily intake of each food item was
calculated by multiplying the consumption frequency by
the typical portion size and the number of servings. We
excluded 167 individuals for whom we did not have in-
formation on white rice intake. To further investigate
the association between white rice intake and T2DM, we
divided the participants into quartiles of daily white rice
consumption; ≤71.1, 71.2–120, 120.1–210 and >210
grams/day.
TLGS
A validated semi-quantitative FFQ was used to collect
dietary information in phase III [26]. Trained dietitians
with at least 5 years of experience in TLGS asked partic-
ipants to designate their consumption frequency for
each food item consumed during the previous year on a
daily, weekly, or monthly basis. Portion sizes of con-
sumed foods that were reported in household measures
were then converted to grams [3].
The median white rice intake in this population was
250 grams/day (equivalent of ‘one dish’ of cooked white
rice) and 36% of the participants reported this amount
as their intake level. Thus, white rice intake in TLGS
was categorized into three groups less than 250, 250 and
more than 250 grams/day.
Outcome assessment
GCS participants who had FPG ≥ 126 mg/dl, HbA1c >
6.5% [27] or were receiving treatment for diabetes were
categorized as having confirmed incident T2DM. In
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Fig. 1 Selection process of eligible participants in Golestan Cohort Study
Fig. 2 Selection process of eligible participants in Tehran Lipid and Glucose Study
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TLGS phase IV, participants with FPG ≥ 126 mg/dl or 2-
h plasma glucose ≥ 200 mg/dl during an oral plasma glu-
cose tolerance test or taking anti-diabetic medications
were considered as cases.
Potential confounders
All participants in both studies underwent interviews by
trained physicians and/or technicians and information
on demographics and other baseline lifestyle behaviors
were collected using structured lifestyle questionnaires.
Anthropometric indices were measured after the inter-
views by trained technicians.
Potential confounders assessed in both studies in-
cluded age, sex, education (highest level attained), mari-
tal status, employment status, smoking, physical activity
(physical activity at work estimated from the intensity of
the daily work and the amount of time spent at work in
GCS and total physical activity calculated from informa-
tion collected via a validated modifiable activity ques-
tionnaire in TLGS) [28]. Our aim was to estimate the
effect of substituting white rice with other sources of
carbohydrates or fat. Therefore, we adjusted for total cal-
orie intake and daily meat (red meat, poultry and fish)
intake. Additional confounders included in the GCS ana-
lysis were race (Turkman vs. non-Turkman), urban or
rural residence, wealth score (a surrogate of socioeco-
nomic status (SES), calculated from appliance ownership
[29]), opium and alcohol consumption and self-reported
hypertension status. In TLGS, we also adjusted the
models for family history of T2DM.
The GCS was approved by the Institutional Review
Boards of the Digestive Disease Research Institute of
Tehran University of Medical Sciences, the US National
Cancer Institute (NCI), and the World Health
Organization International Agency for Research on Can-
cer (IARC). TLGS was approved by the institutional re-
view board of the Research Institute for Endocrine
Sciences, Shahid Beheshti University of Medical Sci-
ences. All participants gave written informed consent be-
fore enrollment.
Statistical analysis
We used the World Standard Population 2000–2005 de-
veloped by the WHO [20] to calculate age-standardized
rates. Multivariable logistic regression models were used
to estimate crude and adjusted odds ratios (ORs) and
the corresponding 95% confidence interval (CI)s. Models
were initially adjusted for age and sex and further for all
other potential confounders mentioned above. Selection
of confounders was based on prior knowledge. We ex-
amined if the association between white rice intake and
T2DM was modified by selected baseline characteristics
(age (above or below 50 years), sex and physical activity
in both studies and ethnicity and residence in GCS) by
including product terms in the models. Since some of
the effect of white rice intake on T2DM may be medi-
ated through weight gain, we did not include body mass
index (BMI) or waist circumference (WC) in our main
analysis.
We used data on demographics and other baseline life-
style behaviors and dietary information obtained during
interview at enrollment in GCS and phase III in TLGS.
Laboratory measurements obtained in the re-
measurement study in GCS (2011–2013) and fourth
phase of TLGS (2009–2011) were used to determine dia-
betes status.
Sensitivity analyses
As adjusting for total calorie intake as a covariate in the
model may not be sufficient, in a sensitivity analysis, we
used the ‘residual method’ for energy adjustment [30]. In
GCS, we first used a Box-Cox power transformation to
determine the appropriate exponent (theta = 0.28) that
would transform the distribution of white rice intake
into a Normal distribution. The residual of the regres-
sion of the box-cox transformed white rice intake on
total calorie intake was then categorized into quartiles
and used as the dependent variable. In TLGS, however,
the insufficient number of events in the exposure cat-
egories of calorie-adjusted white rice intake limited our
ability to perform sensitivity analysis using residual ad-
justment method.
We further assessed the sensitivity of our results in
GCS to selection bias due to differential survival using
inverse probability weighting (IPW). This was done
mainly since Golestan is an older cohort (average age
51 years old) and we had 2,451 deaths during the follow
up. We estimated the probability of death during the
5 years of follow up using a logistic regression model
conditional on all the risk factors of both death and
T2DM and assigned the reciprocal of the estimated
probability to each individual. This approach allows us
to create a pseudo-population in which there is no cen-
soring by death (non-stabilized weights) or censoring by
death is independent of measured determinants of sur-
vival included in the IPW models (stabilized weights)
[31]. Finally, we looked at the association between cat-
egories of white rice intake and FPG (defined as above
126 mg/dl) in both studies. All tests of hypothesis were
conducted at a confidence level of 0.95 under the two-
sided alternative.
Results
A total of 9,182 participants from GCS and 2,173 from
TLGS were eligible for this analysis (Figs. 1 and 2). Par-
ticipants were on average (±SD) 51 (±8) years old at re-
cruitment in GCS and 39 (±13) in TLGS at baseline. We
documented 902 diagnosed T2DM in GCS and 81 in
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Table 1 Baseline Characteristics of Study Participants According to Quartiles of White Rice Intake in Re-measurement Sub-cohort,
Golestan Cohort Study (2004–2007)
≤71.1 (n = 2267) 71.2–120 (n = 2679) 120.1–210 (n = 1990) >210 (n = 2393) P-value
Median rice intake, g/day 51.4 107.1 171.4 257.1
Diabetes Mellitus diagnosed during re-measurement study, N (%)a
No 2027 (90.1) 2434 (91.2) 1784 (90.1) 2035 (89.1) 0.114
Yes 223 (9.9) 235 (8.8) 196 (9.9) 248 (10.2)
Age Categories, N (%)
Below 45 433 (19.1) 637 (23.8) 461 (23.2) 554 (24.2) <0.001
45–49 540 (23.8) 664 (24.8) 557 (28.0) 632 (27.6)
50–54 467 (20.6) 541 (20.2) 417 (20.9) 463 (20.2)
55–59 375 (16.5) 400 (14.9) 274 (13.8) 336 (14.7)
60 and above 452 (19.9) 437 (16.3) 281 (14.1) 308 (13.4)
Female, N (%) 1420 (62.6) 1575 (58.8) 903 (45.4) 856 (37.3) <0.001
Turkmen, N (%) 1504 (66.3) 2160 (80.6) 1521 (76.4) 1919 (83.7) <0.001
Rural, N (%) 1892 (83.5) 2208 (82.4) 1475 (74.2) 1718 (74.9) <0.001
Wealth score, N (%)
Low 815 (36.0) 667 (24.9) 390 (19.6) 380 (16.6) <0.001
Low-Medium 583 (25.7) 546 (20.4) 362 (18.2) 328 (14.3)
Medium-High 515 (22.7) 778 (29.0) 533 (26.8) 601 (26.2)
High 354 (15.6) 688 (25.7) 705 (35.4) 984 (42.9)
Education, N (%)
Illiterate 1809 (79.8) 1887 (70.4) 1134 (57.0) 1167 (50.9) <0.001
Primary School 303 (13.4) 467 (17.4) 428 (21.5) 542 (23.6)
Middle School or Higher 155 (6.8) 325 (12.1) 428 (21.5) 584 (25.5)
Married, N (%) 1945 (85.8) 2403 (89.7) 1849 (92.9) 2197 (95.8) <0.001
Currently working, N (%) 1974 (87.1) 2407 (89.8) 1812 (91.1) 2109 (92.0) <0.001
Tobacco, N (%)
Never Smoker 1823 (80.4) 2177 (81.3) 1545 (77.6) 1731 (75.5) <0.001
Former Smoker 116 (5.1) 159 (5.9) 148 (7.4) 181 (7.9)
Current Smoker 223 (9.9) 246 (9.2) 228 (11.5) 322 (14.0)
Ever-hookah, nass or pipe userb 105 (4.6) 97 (3.6) 69 (3.5) 59 (2.6)
Regular Alcohol Consumption, N (%) 48 (2.1) 87 (3.3) 103 (5.2) 131 (5.7) <0.001
Opium Use, N (%) 360 (15.9) 360 (13.4) 269 (13.5) 320 (14.0) 0.006
Physical Activity, N (%)
Mild 1443 (63.6) 1623 (60.6) 1043 (52.4) 1115 (48.6) <0.001
Moderate 528 (23.3) 741 (27.6) 695 (34.9) 852 (37.2)
Intense 296 (13.1) 315 (11.8) 252 (12.7) 326 (14.2)
Hypertension, N (%) 947 (41.8) 1059 (39.5) 751 (37.7) 853 (37.2) 0.007
Anthropometric Indices
Body mass index (BMI) Categories, N (%)
Underweight (BMI < 18.5) 137 (6.0) 97 (3.6) 53 (2.7) 43 (1.9) <0.001
Normal (20≤ BMI < 25) 944 (41.6) 989 (36.9) 643 (32.8) 693 (29.8)
Overweight (25≤ BMI < 30) 702 (31.0) 927 (34.6) 732 (37.4) 918 (39.5)
Obese (BMI ≥ 30) 484 (21.4) 666 (24.9) 532 (27.1) 669 (28.8)
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TLGS (see Additional file 1: Table S1). Age-standardized
cumulative incidence of T2DM was 9.9% in GCS over
5 years and 8.0% in TLGS over three years. Characteris-
tics of study participants by categories of white rice in-
take in both studies are presented in Tables 1 and 2.
Carbohydrate intake accounted for 56.9% and 57.7% of
the total daily energy intake GCS and TLGS, respect-
ively. In GCS, white rice was responsible for 8% of total
energy intake and 14% of total carbohydrate intake. In
TLGS, these figures were 15.7% and 27%, respectively.
The median (interquartile range (IQR)) daily white rice
intake was 120 grams (77, 210) in GCS and 250
grams (143, 250) in TLGS. Compared to Golestan,
residents of Tehran consumed significantly more
white rice on a daily basis (P-value for Wilcoxon
signed-rank test < 0.001). Daily calorie intake mean
was also significantly higher in TLGS (2,425 (±1,098)
kCal/day in TLGS vs 2231 (±612) kCal/day in GCS;
P-value < 0.001). Meat, on the other hand, was consumed
significantly more in Golestan (80 (±50.3) vs 63 (±53.5)
grams/day; P-value < 0.001).
In Golestan, non-Turkmens, urban residents, individ-
uals with higher wealth scores, some education, who
were currently working, married and were physically
more active were more likely to report consuming more
than 210 grams of white rice per day. Smoking, alcohol
intake, BMI and WC were positively and opium use was
negatively associated with white rice intake. In TLGS,
marital status and physical activity were negatively and
smoking was positively associated with white rice intake.
Finally, higher white rice intake was associated with
higher daily meat and calorie intake in both studies.
In both crude and fully adjusted models, there was no
significant association between white rice and incidence
T2DM in GCS (Table 3). In TLGS, the crude OR (95%
CI) was 1.18 (0.68, 2.04) and the fully adjusted OR was
2.08 (1.10, 3.91) comparing participants with white rice
intake of >250 grams/day to those with <250. The nega-
tive confounding pattern is partly due to differences in
age and SES where the younger, currently working and
more educated participants had higher intake levels
(Table 1, Additional file 2: Table S2). The ORs of dia-
betes obtained from the energy-adjusted white rice in-
take (residual method) in GCS were almost identical to
the above results (see Additional file 3: Table S3). The
IPW analysis did not change the ORs of diabetes in GCS
materially (see Additional file 3: Table S3).
Using FPG as the outcome instead of T2DM, we
observed comparable associations in both studies
(Additional file 4: Table S4). Similar to T2DM, we ob-
served no association between FPG and white rice in-
take in GCS. In TLGS, however, the effect of white
rice intake on FPG was slightly stronger compared to
its effect on T2DM.
Further analyses revealed no modification of the effect
in different strata of age, sex, physical activity, race/eth-
nicity and residence in GCS (Table 4). In TLGS, on the
other hand, we observed stronger associations between
white rice intake and T2DM in men and individuals with
moderate total physical activity (P values for trend
<0.05). The fully adjusted OR for T2DM for consuming
250 grams/day of white rice was 3.11 (1.23, 7.87) in men
(Table 4).
Discussion
In these two prospective population-based cohort stud-
ies of rural and urban areas in Iran, we observed an as-
sociation between white rice intake and T2DM only in
urban areas. While we detected a significant doubling of
incidence of diabetes in those with white rice intake
more than 250 grams/day in TLGS, in Tehran, we did
not observe a significant association in the GCS, in
Golestan. The observed association in TLGS was more
pronounced in men.
Several prospective studies have reported a positive asso-
ciation between white rice intake and diabetes [10, 11, 32].
Hu et al. conducted a meta-analysis on seven prospective
cohort studies conducted in Asian and Western popula-
tions and observed an overall 27% increased risk of diabetes
comparing high versus low white rice consumption levels.
Table 1 Baseline Characteristics of Study Participants According to Quartiles of White Rice Intake in Re-measurement Sub-cohort,
Golestan Cohort Study (2004–2007) (Continued)
Waist circumference, Mean (SD)
Men 90.7 (12.7) 93.0 (12.8) 95.7 (12.8) 98.3 (12.6) <0.001
Women 93.98 (14.2) 95.83 (14.1) 97.35 (13.0) 98.53 (13.0) <0.001
Food and Nutrient Intake
Mean (SD) Carbohydrate Intake, g/day 291.5 (98.6) 308.4 (91.8) 329.2 (90.8) 346.7 (99.1) <0.001
Mean (SD) Meat Intake, g/day 72.1 (56.0) 76.4 (52.4) 81.9 (51.3) 93.7 (58.5) <0.001
Mean (SD) Calorie Intake, kCal/day 2024.8 (603.7) 2168.4 (569.1) 2307.7 (565.5) 2456.3 (620.4) <0.001
aThe numbers of individuals with and without type 2 diabetes mellitus don’t add up to the total number of participants in some of the categories of
white rice consumption due to the missing information of diabetes status on some of the individuals in those categories. bnass: a mixture of tobacco,
lime and ash
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Table 2 Baseline Characteristics of Participants by Categories of White Rice Intake (g/day) in Phase III, Tehran Lipid and Glucose
Study (2004–2006)
<250 (n = 876) 250 (n = 778) >250 (n = 519) P-value
Median rice intake, g/day 125 250 390
Diabetes Mellitus diagnosed at phase IV, N (%)a
No 843 (96.3) 753 (96.8) 496 (95.6) 0.524
Yes 33 (3.7) 25 (3.2) 23 (4.4)
Age Categories, N (%)
Below 30 198 (22.6) 203 (26.1) 197 (38.0) <0.001
30–39 208 (23.7) 211 (27.1) 136 (26.2)
40–49 228 (26.0) 175 (22.5) 107 (20.6)
50–59 148 (16.9) 111 (14.3) 52 (10.0)
60 and above 94 (10.7) 78 (10) 27 (5.2)
Female, N (%) 564 (64.4) 441 (56.7) 192 (37.0) <0.001
Education, N (%)
High School or lower 264 (30.1) 226 (29.1) 118 (22.7) 0.042
High School Diploma 393 (44.9) 349 (44.9) 250 (48.2)
Above High School Diploma 219 (25.0) 203 (26.1) 151 (29.1)
Married, N (%) 689 (78.7) 588 (75.6) 364 (70.1) 0.002
Currently working, N (%) 350 (40.0) 356 (45.8) 325 (62.6) <0.001
Tobacco, N (%)
Never Smoker 668 (76.3) 552 (71.0) 323 (62.2) <0.001
Former Smoker 49 (5.6) 55 (7.1) 41 (7.9)
Current Smoker 159 (18.2) 170 (21.9) 155 (29.9)
Total Physical Activity, N (%)
Light 322 (36.8) 317 (40.8) 227 (43.7) 0.005
Moderate 217 (24.8) 142 (18.3) 107 (20.6)
Vigorous 337 (38.5) 319 (41.0) 185 (35.7)
Family History of Diabetes, N (%) 166 (19.0) 146 (18.8) 101 (19.5) 0.951
Anthropometric Indices
Body mass index (BMI) Categories at Baseline, N (%)
Underweight (BMI < 18.5) 9 (1.0) 11 (1.4) 3 (0.6) <0.001
Normal (20≤ BMI < 25) 225 (25.7) 218 (28.0) 171 (33.0)
Overweight (25≤ BMI < 30) 348 (39.7) 347 (44.6) 222 (42.8)
Obese (BMI≥ 30) 294 (33.6) 202 (26.0) 123 (23.7)
Waist circumference, Mean (SD)
Men 95.2 (11.1) 93.8 (10.8) 94.1 (10.8) 0.101
Women 86.3 (13.0) 84.7 (13.3) 83.7 (14.0) 0.015
Food and Nutrient Intake
Mean (SD) Carbohydrate Intake, g/day 290.6 (126.9) 351.9 (180.8) 448.8 (252.7) <0.001
Mean (SD) Meat Intake, g/day 57.3 (6.3) 62.3 (52.5) 72.5 (63.8) <0.001
Mean (SD) Calorie Intake, kCal/day 2072.7 (822.4) 2446.1 (1077.9) 2963.5 (1298.7) <0.001
aThe numbers of individuals with and without type 2 diabetes mellitus don’t add up to the total number of participants in some of the categories of white rice
consumption due to the missing information of diabetes status on some of the individuals in those categories
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This effect was more pronounced in Asian populations that
consume white rice at larger quantities (55% increase risk)
[12]. We observed a doubling of diabetes risk associated
with >250 grams of white rice intake in TLGS. This finding
is in line with but stronger than the results of the prospect-
ive Asian studies. The Shanghai Women’s Health Study re-
ported a 78% higher risk of diabetes with >300 grams/day
of raw white rice intake (compared to less than 200 grams
of raw white rice intake) [11] and the Japanese Public
Health Center-based Prospective Study (Women) showed
65% increase in diabetes risk with consuming >437 grams
of cooked white rice each day compared to comsuming
<287 grams of daily cooked white rice [10]. Similarly, regu-
lar white rice intake was associated with increased risk and
replacement of white rice with whole grain was associated
with a reduced risk of diabetes in US men and women [32].
The differences in the effect of white rice on diabetes across
various populations can be due to different carbohydrate
quantity and quality. The effect of white rice on diabetes
could be more pronounced in developing countries under-
going nutritional transition. Fat accumulation through in-
creased intake of calorie-dense diet, and lack of physical
activity could make people living in these countries more
susceptible to the adverse effects of higher white rice
intake.
The exact mechanism through which white rice in-
take may increase the risk of diabetes is not clear, but
postprandial blood glucose surge (measured by the
GI) and further induction of insulin resistance has
been implicated as a possible mechanism [33]. Both
the GI and glycemic load have been associated with
increased risk of metabolic syndrome and diabetes in
several prospective cohort studies [11, 17–19]. The GI
of white rice depends on the proportion of the amyl-
ose content of the grain in addition to the cooking
time and the degree of processing [16]. But in gen-
eral, the GI value of white rice has been reported to
be higher than that of brown rice and other whole
grains [16]. In addition, the milling process removes
the outer bran layer of the grain which contains im-
portant nutrients such as magnesium and fibers
which have been associated with decreased risk of
diabetes [14, 15].
The contribution of white rice to the total energy in-
take was generally low in both studies analyzed here (8%
in GCS and 15.7% in TLGS), while carbohydrate ac-
counts for approximately 60% of the total daily energy
intake. This indicates that other foods containing high
carbohydrates (such as bread) are being consumed at
high quantities in these populations. Bread is considered
a main staple in Golestan and the median daily bread in-
take in Golestan was 352 grams, which accounted for
approximately 52% of total carbohydrate and 30% of
total calorie intake.
The discrepancy between the results of the GCS and
TLGS may be due to (1) lower levels of exposure in the
GCS; (2) effect measure modification; or (3) differences in
measurement or residual confounding between the two
studies. On average, GCS participants consumed 97
grams/day less white rice and white rice only contributed
Table 3 Odds ratio (OR) (95% confidence interval (CI)) of type 2 diabetes mellitus according to different categories of white rice























Quartiles of White Rice Intake
≤ 71.1 g/day 2,267 223 1 0.14 1 0.02 1 0.42 1 0.54
71.2-120 g/day 2,679 235 0.88 (0.72, 1.06) 0.90 (0.75, 1.10) 0.89 (0.73, 1.08) 0.85 (0.69, 1.04)
120.1-210 g/day 1,990 196 1.00 (0.82, 1.22) 1.07 (0.87, 1.32) 0.94 (0.76, 1.17) 0.84 (0.68, 1.06)
> 210 g/day 2,393 248 1.11 (0.92, 1.34) 1.22 (1.01, 1.48) 1.05 (0.85, 1.30) 0.90 (0.73, 1.12)
TLGS†
Categories of White Rice Intake
< 250 g/day 876 33 1 0.63 1 0.09 1 0.05 1 0.03
250 g/day 778 25 0.84 (0.50, 1.45) 0.94 (0.55, 1.61) 1.01 (0.58, 1.75) 1.08 (0.61, 1.92)
> 250 g/day 519 23 1.18 (0.68, 2.04) 1.78 (1.00, 3.17) 2.08 (1.10, 3.91) 2.28 (1.19, 4.37)
* Models were adjusted for age categories (below 45, 45–49, 50–54, 55–59, 60 and above), sex (female, male), race/ethnicity (Turkmen, non-Turkmen), wealth
score (low, low-medium, medium or high), education (illiterate, primary school, middle school or higher) marital status (single, married), employment status
(employed, unemployed), opium (yes, no), alcohol (yes, no), occupational physical activity (mild, moderate, intense), smoking (never, former, current, ever hookah,
nass or pipe user), quartiles of daily meat intake (g/d; ≤45, 45.1-69.8, 69.9-102.8, >102.8) and quartiles of daily calorie intake (kcal/d; ≤1840.8, 1840.9-2189.5,
2189.6-2552.4, >2552.4). † Models were adjusted for age categories (below 30, 30–39, 40–9, 50–59, 60 and above), sex (female, male), family history of type 2
diabetes mellitus (yes/no), education (no high school diploma, high school diploma, some university training), marital status (single, married), employment status
(employed, unemployed), total physical activity (metabolic equivalent task hours per day categorized as light, moderate, intense), smoking (never, former, current),
quartiles of daily meat intake (g/d; ≤32.3, 32.3-50.6, 50.7-76.8, >76.8) and quartiles of daily calorie intake (kcal/d; <1765.1, 1765.1-2237.3, 2237.4-2830.1, >2830.1)
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to 14% of the total daily carbohydrate intake (compared to
27% in TLGS). It is possible that higher consumption
levels are required for white rice to affect diabetes risk
[12]. The GCS was conducted in Golestan province, a pre-
dominantly rural province which is less developed eco-
nomically than major cities such as Tehran. This may lead
to different levels of lifestyle and environmental factors
that may act as effect modifiers. Specifically, it is also pos-
sible that GCS participants are consuming more of other
forms of carbohydrates, namely bread, that are richer in
insoluble fibers and magnesium, and the beneficial anti-
diabetic effects of these nutrients could potentially cancel
out the adverse effect of white rice. Additionally, GCS par-
ticipants are mostly farmers and are more likely to have
an active lifestyle compared to residents of Tehran, who
are mostly white-collar workers. Physical activity was not
measured with the same tool in both studies so we could
not directly compare physical activity levels between the
two cohorts. A specific source of bias in the GCS is that
blood glucose was not measured at baseline so some of
the diabetes cases in our analysis may indeed be prevalent
cases and this will bias the estimates towards the null. We
also expect larger residual or unmeasured confounding by
SES in TLGS compared to the GCS as the only SES vari-
able available in TLGS was education.
This study has some limitations. First, information on
the date of diagnosis of diabetes was not available in
either study, so we could not conduct a time-to-event
analysis. Second, measurement errors in dietary intake
elicited using FFQs cannot be ruled out, even though
both FFQs have been previously shown to provide reli-
able and valid estimates of nutrients and energy intake
[25, 26]. It is possible the FFQs used in the two studies
have different accuracy white rice intake measurement.
Table 4 Odds ratio (OR) (95% confidence interval (CI)) of type 2 diabetes mellitus according to white rice intake by age categories,
sex, physical activity, race/ethnicity and residence intake in Golestan Cohort Study (GCS) and Tehran Lipid and Glucose Study (TLGS),
(2004–2007)
GCS* TLGS†
White Rice Intake (grams/day) P for trend White Rice Intake (grams/day) P for trend
N ≤71.1 71.2-120 120.1-210 >210 N <250 250 >250
Age
Below 50 4,751 1 1.03 (0.75, 1.43) 1.22 (0.88, 1.70) 1.10 (0.78, 1.54) 0.11 1,663 1 1.54 (0.64, 3.70) 2.40 (0.88, 6.35) 0.11
Above 50 4,478 1 0.80 (0.62, 1.03) 0.77 (0.57, 1.02) 1.03 (0.79, 1.36) 0.15 510 1 0.75 (0.36, 1.57) 2.02 (0.85, 4.77) 0.20
P-value for interaction 0.31 0.04 1.0 0.29 0.89
Sex
Female 4,754 1 1.00 (0.78, 1.29) 1.03 (0.77, 1.38) 1.11 (0.83, 1.49) 0.53 1,197 1 0.88 (0.42, 1.83) 1.52 (0.57, 4.07) 0.71
Male 4,475 1 0.70 (0.50, 0.98) 0.85 (0.61, 1.18) 0.95 (0.69, 1.30) 0.56 976 1 1.45 (0.58, 3.61) 3.11 (1.23, 7.87) 0.02
P-value for interaction 0.12 0.53 0.75 0.36 0.20
Physical Activity
Mild 5,224 1 1.06 (0.83, 1.35) 0.81 (0.61, 1.09) 1.13 (0.85, 1.50) 0.345 866 1 1.04 (0.44, 2.48) 2.22 (0.83, 5.97) 0.17
Moderate 2,816 1 0.65 (0.43, 0.98) 1.27 (0.87, 1.87) 1.07 (0.73, 1.57) 0.09 466 1 2.50 (0.57, 11.11) 9.86 (2.10, 46.18) 0.01
Intense 1,189 1 0.60 (0.31, 1.16) 0.60 (0.30, 1.19) 0.68 (0.35, 1.34) 0.34 841 1 0.69 (0.28, 1.69) 0.74 (0.10, 2.56) 0.42
P-value for interaction** 0.79, 0.33 0.04, 0.98 1.0, 0.66 0.29, 0.04 0.54, 0.19
Race/Ethnicity
Turkmen 7,104 1 0.86 (0.67, 1.09) 0.94 (0.72, 1.22) 1.05 (0.82, 1.36) 0.43
Non-Turkmen 2,125 1 0.97 (0.69, 1.38) 0.99 (0.68, 1.45) 1.07 (0.71, 1.61) 0.74
P-value for interaction 0.49 0.75 0.81
Residence
Rural 7,293 1 0.90 (0.72, 1.13) 0.88 (0.68, 1.14) 1.04 (0.81, 1.34) 0.62
Urban 1,936 1 0.93 (0.60, 1.43) 1.18 (0.77, 1.79) 1.16 (0.76, 1.78) 0.33
Pcpovalue for interaction 0.79 0.59 0.82
* Models were adjusted for wealth score (low, low-medium, medium or high), education (illiterate, primary school, middle school or higher) marital status (single,
married), employment status (employed, unemployed), opium (yes, no), alcohol (yes, no), smoking (never, former, current, ever hookah, nass or pipe user),
quartiles of daily meat intake (g/d; ≤45, 45.1-69.8, 69.9-102.8, >102.8) and quartiles of daily calorie intake (kcal/d; ≤1840.8, 1840.9-2189.5, 2189.6-2552.4, >2552.4).
Each model was also additionally adjusted for other covariates not stratified for. † Models were adjusted for family history of type 2 diabetes mellitus (yes/no),
education (no high school diploma, high school diploma, some university training), marital status (single, married), employment status (employed, unemployed),
smoking (never, former, current), family history of diabetes mellitus (yes, no), quartiles of daily meat intake (g/d; ≤32.3, 32.3-50.6, 50.7-76.8, >76.8) and quartiles of
daily calorie intake (kcal/d; <1765.1, 1765.1-2237.3, 2237.4-2830.1, >2830.1). Each model was also additionally adjusted for other covariates not stratified for. **Two
P-values for interactions are presented; the first represent P-values for the interactions between moderate physical activity and categories of white rice
consumption and the second represent p-values for the interaction between intense physical activity and categories of white rice intake
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However, validity and reliability of both FFQs have been
shown to be comparable [25, 26], so the difference in
measurement errors was less likely to explain the
observed difference in the association between T2DM
and white rice intake. Additionally, dietary information
was gathered before diabetes diagnosis in both studies.
Thus, any measurement error in white rice intake would
be non-differential. Although we have previously shown
a notable agreement between self-reported diabetes and
diabetes as defined by measurements of blood glucose
[34], the self-reported nature of diabetes assessment at
baseline in Golestan could have led to overestimation of
diabetes incidence in this population. Third, the rela-
tively small sample size in TLGS affected the reliability
of some of the estimates from the stratified analyses (i.e.,
physical activity). Finally, the possibility of residual con-
founding by unmeasured confounders or measure-
ment error in measured confounders cannot be ruled
out.
Some of the strengths of this study include its large
sample size, accurate outcome assessment (FPG in both
studies, HbA1c in GCS and 2-h plasma glucose in
TLGS) and available data on many potential con-
founders as well as the opportunity to assess the associ-
ation between white rice intake and diabetes in urban
and rural populations in the Middle East.
Conclusion
In summary, we observed an increased likelihood of
T2DM associated with high white rice intake among
residents of Tehran and no association in Golestan.
Our findings, if further supported by other studies,
have important public health implications for other
countries in the Middle East and North Africa as well
as countries in South, East and South East Asia
where white rice is a major staple and diabetes is
increasing rapidly [1]. Introducing whole grains and
replacing white rice with whole grain carbohydrates
can be one of the strategies for prevention of T2DM.
Our study was a step towards investigating the role
of refined carbohydrates on incidence of T2DM in an
area with increasing rates of the disease. Future re-
search should focus on assessing the impact of other
commonly used refined carbohydrate including bread,
especially in rural areas and in areas with lower levels
of white rice intake.
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